Serum thrombopoietin and erythropoietin levels in patients with acute promyelocytic leukaemia during all-trans retinoic acid treatment

Kentaro Kinjo, Masahiro Kizaki, Nobuyuki Takayama, Naohiko Michikawa, Atsushi Oda, Shin Ichiro Okamoto, Tomoyuki Tahara, Takashi Kato, Hiroshi Miyazaki, Yasuo Ikeda

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Endogenous serum thrombopoietin (TPO) and various cytokines including erythropoietin (EPO), interleukin (IL)-3, IL-6, IL-11, granulocyte-colony stimulating factor (G-CSF), granulocyte-macrophage-colony stimulating factor (GM-CSF) and stem cell factor (SCF) levels were measured in five patients with acute promyelocytic leukaemia (APL) during all-trans retinoic acid (RA) treatment. During differentiation-inducing therapy, platelet counts slowly increased and reached a peak between days 29 and 46 (median day 35). Serum TPO levels increased parallel to the increasing platelet counts and reached a maximum level during the first 10-20d of all-trans RA treatment. The circulating TPO levels then decreased in inverse correlation to the platelet counts. These unique changes in serum TPO levels revealed that TPO levels were not regulated by platelet or megakaryocyte mass in patients with APL during differentiation-inducing therapy, and it would appear that TPO levels are directly regulated by all-trans RA during the first 10-20d of treatment. In addition, the change in circulating EPO levels and reticulocyte counts were similar to that of the TPO levels and platelet counts during all-trans RA treatment, suggesting a close relationship between TPO and EPO signalling.

Original languageEnglish
Pages (from-to)382-387
Number of pages6
JournalBritish Journal of Haematology
Volume105
Issue number2
Publication statusPublished - 1999
Externally publishedYes

Fingerprint

Thrombopoietin
Acute Promyelocytic Leukemia
Erythropoietin
Tretinoin
Serum
Platelet Count
Therapeutics
Interleukin-11
Reticulocyte Count
Stem Cell Factor
Megakaryocytes
Interleukin-3
Granulocyte Colony-Stimulating Factor
Granulocyte-Macrophage Colony-Stimulating Factor
Interleukin-6
Blood Platelets
Cytokines

Keywords

  • Acute promyelocytic leukaemia
  • All-trans retinoic acid
  • Erythropoietin
  • Thrombopoietin

ASJC Scopus subject areas

  • Hematology

Cite this

Kinjo, K., Kizaki, M., Takayama, N., Michikawa, N., Oda, A., Okamoto, S. I., ... Ikeda, Y. (1999). Serum thrombopoietin and erythropoietin levels in patients with acute promyelocytic leukaemia during all-trans retinoic acid treatment. British Journal of Haematology, 105(2), 382-387.

Serum thrombopoietin and erythropoietin levels in patients with acute promyelocytic leukaemia during all-trans retinoic acid treatment. / Kinjo, Kentaro; Kizaki, Masahiro; Takayama, Nobuyuki; Michikawa, Naohiko; Oda, Atsushi; Okamoto, Shin Ichiro; Tahara, Tomoyuki; Kato, Takashi; Miyazaki, Hiroshi; Ikeda, Yasuo.

In: British Journal of Haematology, Vol. 105, No. 2, 1999, p. 382-387.

Research output: Contribution to journalArticle

Kinjo, K, Kizaki, M, Takayama, N, Michikawa, N, Oda, A, Okamoto, SI, Tahara, T, Kato, T, Miyazaki, H & Ikeda, Y 1999, 'Serum thrombopoietin and erythropoietin levels in patients with acute promyelocytic leukaemia during all-trans retinoic acid treatment', British Journal of Haematology, vol. 105, no. 2, pp. 382-387.
Kinjo, Kentaro ; Kizaki, Masahiro ; Takayama, Nobuyuki ; Michikawa, Naohiko ; Oda, Atsushi ; Okamoto, Shin Ichiro ; Tahara, Tomoyuki ; Kato, Takashi ; Miyazaki, Hiroshi ; Ikeda, Yasuo. / Serum thrombopoietin and erythropoietin levels in patients with acute promyelocytic leukaemia during all-trans retinoic acid treatment. In: British Journal of Haematology. 1999 ; Vol. 105, No. 2. pp. 382-387.
@article{9533bc76de084c2c97c57ac37b66ab6e,
title = "Serum thrombopoietin and erythropoietin levels in patients with acute promyelocytic leukaemia during all-trans retinoic acid treatment",
abstract = "Endogenous serum thrombopoietin (TPO) and various cytokines including erythropoietin (EPO), interleukin (IL)-3, IL-6, IL-11, granulocyte-colony stimulating factor (G-CSF), granulocyte-macrophage-colony stimulating factor (GM-CSF) and stem cell factor (SCF) levels were measured in five patients with acute promyelocytic leukaemia (APL) during all-trans retinoic acid (RA) treatment. During differentiation-inducing therapy, platelet counts slowly increased and reached a peak between days 29 and 46 (median day 35). Serum TPO levels increased parallel to the increasing platelet counts and reached a maximum level during the first 10-20d of all-trans RA treatment. The circulating TPO levels then decreased in inverse correlation to the platelet counts. These unique changes in serum TPO levels revealed that TPO levels were not regulated by platelet or megakaryocyte mass in patients with APL during differentiation-inducing therapy, and it would appear that TPO levels are directly regulated by all-trans RA during the first 10-20d of treatment. In addition, the change in circulating EPO levels and reticulocyte counts were similar to that of the TPO levels and platelet counts during all-trans RA treatment, suggesting a close relationship between TPO and EPO signalling.",
keywords = "Acute promyelocytic leukaemia, All-trans retinoic acid, Erythropoietin, Thrombopoietin",
author = "Kentaro Kinjo and Masahiro Kizaki and Nobuyuki Takayama and Naohiko Michikawa and Atsushi Oda and Okamoto, {Shin Ichiro} and Tomoyuki Tahara and Takashi Kato and Hiroshi Miyazaki and Yasuo Ikeda",
year = "1999",
language = "English",
volume = "105",
pages = "382--387",
journal = "British Journal of Haematology",
issn = "0007-1048",
publisher = "Wiley-Blackwell",
number = "2",

}

TY - JOUR

T1 - Serum thrombopoietin and erythropoietin levels in patients with acute promyelocytic leukaemia during all-trans retinoic acid treatment

AU - Kinjo, Kentaro

AU - Kizaki, Masahiro

AU - Takayama, Nobuyuki

AU - Michikawa, Naohiko

AU - Oda, Atsushi

AU - Okamoto, Shin Ichiro

AU - Tahara, Tomoyuki

AU - Kato, Takashi

AU - Miyazaki, Hiroshi

AU - Ikeda, Yasuo

PY - 1999

Y1 - 1999

N2 - Endogenous serum thrombopoietin (TPO) and various cytokines including erythropoietin (EPO), interleukin (IL)-3, IL-6, IL-11, granulocyte-colony stimulating factor (G-CSF), granulocyte-macrophage-colony stimulating factor (GM-CSF) and stem cell factor (SCF) levels were measured in five patients with acute promyelocytic leukaemia (APL) during all-trans retinoic acid (RA) treatment. During differentiation-inducing therapy, platelet counts slowly increased and reached a peak between days 29 and 46 (median day 35). Serum TPO levels increased parallel to the increasing platelet counts and reached a maximum level during the first 10-20d of all-trans RA treatment. The circulating TPO levels then decreased in inverse correlation to the platelet counts. These unique changes in serum TPO levels revealed that TPO levels were not regulated by platelet or megakaryocyte mass in patients with APL during differentiation-inducing therapy, and it would appear that TPO levels are directly regulated by all-trans RA during the first 10-20d of treatment. In addition, the change in circulating EPO levels and reticulocyte counts were similar to that of the TPO levels and platelet counts during all-trans RA treatment, suggesting a close relationship between TPO and EPO signalling.

AB - Endogenous serum thrombopoietin (TPO) and various cytokines including erythropoietin (EPO), interleukin (IL)-3, IL-6, IL-11, granulocyte-colony stimulating factor (G-CSF), granulocyte-macrophage-colony stimulating factor (GM-CSF) and stem cell factor (SCF) levels were measured in five patients with acute promyelocytic leukaemia (APL) during all-trans retinoic acid (RA) treatment. During differentiation-inducing therapy, platelet counts slowly increased and reached a peak between days 29 and 46 (median day 35). Serum TPO levels increased parallel to the increasing platelet counts and reached a maximum level during the first 10-20d of all-trans RA treatment. The circulating TPO levels then decreased in inverse correlation to the platelet counts. These unique changes in serum TPO levels revealed that TPO levels were not regulated by platelet or megakaryocyte mass in patients with APL during differentiation-inducing therapy, and it would appear that TPO levels are directly regulated by all-trans RA during the first 10-20d of treatment. In addition, the change in circulating EPO levels and reticulocyte counts were similar to that of the TPO levels and platelet counts during all-trans RA treatment, suggesting a close relationship between TPO and EPO signalling.

KW - Acute promyelocytic leukaemia

KW - All-trans retinoic acid

KW - Erythropoietin

KW - Thrombopoietin

UR - http://www.scopus.com/inward/record.url?scp=0032954540&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032954540&partnerID=8YFLogxK

M3 - Article

VL - 105

SP - 382

EP - 387

JO - British Journal of Haematology

JF - British Journal of Haematology

SN - 0007-1048

IS - 2

ER -